Raquel Blanch-Serrano
Cordoba, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Use of multi-gene panels in patients at high risk of hereditary digestive cancer: position statement of AEG, SEOM, AEGH and IMPaCT-GENÓMICA consortium.
Journal: Gastroenterologia y hepatologia
Published: May 01, 2023
Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus response.
Journal: Molecular therapy. Nucleic acids
Published: February 09, 2023
Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: March 11, 2022
Epigenetic and post-transcriptional regulation of somatostatin receptor subtype 5 (SST5 ) in pituitary and pancreatic neuroendocrine tumors.
Journal: Molecular oncology
Published: September 12, 2020
Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Novel Potential Biomarker in Gastroenteropancreatic Neuroendocrine Tumors.
Journal: Clinical and translational gastroenterology
Published: April 19, 2018
The components of somatostatin and ghrelin systems are altered in neuroendocrine lung carcinoids and associated to clinical-histological features.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 31, 2017
Almost 2% of Spanish breast cancer families are associated to germline pathogenic mutations in the ATM gene.
Journal: Breast cancer research and treatment
Published: September 20, 2016
Rosette-forming glioneuronal tumour (RGNT) of the fourth ventricle: a highly aggressive case.
Journal: Brain tumor pathology
Published: March 23, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026